Retatrutide's weight-loss results compiled across all six peer-reviewed trials
Start here
Retatrutide, an investigational obesity therapy, has now produced weight-loss results across six peer-reviewed trials spanning every dose tested, from placebo up to 12 mg. A newly circulated compilation brings all of those results together in a single chart, allowing readers to compare weight reduction at each dose level directly. The compilation draws on the underlying published studies and has become a focal point of community discussion among researchers and clinicians tracking the drug. Retatrutide's dose-response profile, as assembled in the chart, is the current reference point for public comparison, and the open questions are whether regulators and larger confirmatory trials will bear out the dose-dependent weight loss shown so far.
Written by a model from the reports · updated 2 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- reddit.comPickRetatrutide weight loss at every dose tested: all six peer-reviewed trials, placebo to 12 mg, in one chart (sources inside)
Reddit user u/EmZephyr compiled weight-loss data from six published retatrutide trials, covering doses from placebo to 12 mg. Sources include peer-reviewed papers such as TRIUMPH-1 (NEJM 2026) and TRIUMPH-2 (Lancet 2026); TRIUMPH-3 exists only as a press release, and the first-in-human trial was not included.
Heat trend for this story
Heat now 3·Peak in the comparable set 10 (Oct 22 01:00)·Change over 24h in the comparable set -49%·Participants now 1
Participants counted above, heat below. The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's reading; the left and right arrow keys work too.